Biochemical Parameters in Confirmed Covid-19 Patients: A Hospital Based Study from Eastern Nepal

A Niraula1, B Gelal2, M Lamsal2

  • 1Department of Clinical Biochemistry, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal.

Insights

Biochemical markers such as C-reactive protein, lactate dehydrogenase, and ferritin were elevated in COVID-19 patients. These markers aid in assessing disease severity and guiding treatment for coronavirus disease 2019.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Infectious Diseases

Background:

  • COVID-19 presents with diverse clinical manifestations globally.
  • Effective treatments for COVID-19 remain under development.
  • Understanding biochemical changes is crucial for patient management.

Purpose of the Study:

  • To evaluate biochemical parameters in confirmed COVID-19 patients.
  • To identify potential biomarkers for disease severity assessment.
  • To correlate biochemical findings with clinical status in Nepal.

Main Methods:

  • Retrospective, hospital-based cross-sectional study.
  • Inclusion of 202 confirmed COVID-19 patients admitted to BPKIHS.
  • Analysis of routine biochemical tests using Cobas c311 autoanalyzer.

Main Results:

  • Elevated liver enzymes (ALT, AST, ALP, GGT) and cardiac enzymes (CK-total, CK-MB) were observed.
  • Increased serum ferritin, high-sensitivity C-reactive protein (hs-CRP), and lactate dehydrogenase (LDH) were noted.
  • Over 50% of patients exhibited abnormal biochemical findings.

Conclusions:

  • Biomarkers like hs-CRP, LDH, and ferritin are vital for managing COVID-19.
  • These markers assist in monitoring disease progression and severity.
  • Cost-effective markers such as CRP, LDH, and HbA1c can aid in monitoring COVID-19 infection severity.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
188
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
284
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20